| Company Name: |
Shanghai YuanYe Biotechnology Co., Ltd.
|
| Tel: |
021-61312847; 18021002903 |
| Email: |
3008007409@qq.com |
| Products Intro: |
Product Name:Fontolizumab (anti-IFNG)
CAS:326859-36-3
Purity:Purity>95% (SDS-PAGE&SEC); Endotoxin Level<1.0EU/mg; Human I Package:100μg Remarks:K13651
|
| Company Name: |
Guangzhou Hongyuan Chemical Co.,Ltd
|
| Tel: |
15817493340 |
| Email: |
981810490@qq.com |
| Products Intro: |
Product Name:Fontolizumab
CAS:326859-36-3
Purity:95% Package:1mg;1g;100g
|
| Company Name: |
Wuhan Chemstan Biotechnology Co., Ltd.
|
| Tel: |
027-65317797 15926423062 |
| Email: |
422450190@qq.com |
| Products Intro: |
Product Name:Fontolizumab
Purity:>95%;1mg/ml Package:200ug;500ug;1mg
|
| Company Name: |
Biolab Reagents
|
| Tel: |
027-65279366 18108604356 |
| Email: |
products@biolabreagent.com |
| Products Intro: |
Product Name:Research Grade Fontolizumab
CAS:326859-36-3
Purity:95% PAGE Package:100ug;1mg
|
| Company Name: |
Wuhan Jingkangen Biomedical Technology Co., Ltd
|
| Tel: |
13720134139 086-15871494362 13720134139 |
| Email: |
orders@jknbiochem.com |
| Products Intro: |
Product Name:Research Grade Fontolizumab
CAS:326859-36-3
Purity:95% Package:100ug:500ug:1mg
|
|
| | Immunoglobulin G1, anti-(human interferon g) (human-mouse monoclonal HuZAF g1-chain), disulfide with human-mouse monoclonal HuZAF light chain, dimer Basic information |
| | Immunoglobulin G1, anti-(human interferon g) (human-mouse monoclonal HuZAF g1-chain), disulfide with human-mouse monoclonal HuZAF light chain, dimer Chemical Properties |
| form | Liquid | | color | Colorless to light yellow |
| | Immunoglobulin G1, anti-(human interferon g) (human-mouse monoclonal HuZAF g1-chain), disulfide with human-mouse monoclonal HuZAF light chain, dimer Usage And Synthesis |
| Uses | Immunoregulatory agent to treat auto-immune diseases. |
| | Immunoglobulin G1, anti-(human interferon g) (human-mouse monoclonal HuZAF g1-chain), disulfide with human-mouse monoclonal HuZAF light chain, dimer Preparation Products And Raw materials |
|